Kimberly-Clark to Acquire Kenvue in $48.7bn Deal
Kimberly-Clark is set to acquire Kenvue in a cash and stock transaction valuing Kenvue at about $48.7 billion.
The transaction would create a company that includes brands such as Kleenex, Huggies, Band-Aid, as well as Tylenol, which has been embattled due to claims by Donald Trump that it increases the risk of autism in children when used by pregnant women.
Mike Hsu, Chairman and CEO of Kimberly-Clark, said the transaction would create “a global health and wellness leader”.
Following the announcement, shares of Kenvue have risen 17 per cent, while Kimberly-Clark shares dropped 12 per cent. After the completion, expected in the second half of 2026, current Kimberly-Clark shareholders will own about 54 per cent of the combined company, while Kenvue shareholders will hold roughly 46 per cent.
Author's summary: Kimberly-Clark acquires Kenvue for $48.7bn.
More News
- Odisha’s Khurda Road Division achieves record freight loading, leads Indian Railways performance
- Massive 16-Foot King Cobra Rescued From House In Balasore | Odisha
- Reflections on Intelligence, With Thomas Sowell and Justice Clarence Thomas
- Dynamic Planner secures 'industry first' AI certification
- Hull’s Community-Owned Pub Raises Glass to Sustainable Future - Hospitality & Catering News
- EU scientists record 99.5% sunlight absorption leap for solar towers
- Whatcom Museum's 'jewel' of an archivist recognized with lifetime achievement award | Cascadia Daily News
- 16-foot King Cobra rescued from house in Odisha's Balasore